Houston, Texas – (Business Wire)- The Board of Directors of Wells Pharma of Houston is pleased to announce the appointment of Tony Schwartz as the organization’s President. Mr. Schwartz brings over twenty years of experience to the position with a wealth of knowledge and an array of experiences specific to building and managing our Pharmaceutical Outsourcing Business.

Tony has been the Vice President of the Company since August 2019 and has been the driving force in assembling our team, preparing our facilities and product lines, and providing consistent leadership over the last 18 months.

“This is a tremendous opportunity to contribute to building and commercializing our 503B Outsourcing business in Houston”, said Tony Schwartz.  “I am tremendously passionate about the compounding industry and I am excited and humbled to be given this opportunity to lead such an extraordinary group of talented professionals here at Wells Pharma.”

Gary L. Shapiro, our current President and Chairman of Wells Pharma of Houston stated that “he and the rest of the Board are delighted to have Mr. Schwartz move into the role of President and lead Wells Pharma into the future.”

Tony’s background in this industry coupled with his exceptional work as Wells Vice President since 2019 will ensure that wells Pharma enjoys continued success in its role as industry leader.

Mr. Schwartz is taking over from Gary Shapiro who has served as president since July 2019 and will continue as Chair and adviser to Management.

About Wells Pharma of Houston, LLC.

Wells Pharma is a leading provider of outsourced compounded sterile preparations to acute care hospitals and surgical centers in the United States. Our sterile preparations offer a strong value proposition to our customers including timely and consistent delivery.